stockrowCalumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) Shares outstanding
Calumet, Inc.'s shares outstanding at the end of fiscal 2025 was $86.8M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $87.6M. Over the past ten years it has ranged from $74.9M (fiscal 2015) to $86.8M (fiscal 2025) — the current reading is the highest in ten years. Calumet, Inc. ranks 26th of 59 Specialty Chemicals companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $86.8M | 4.35% |
| FY2024 | $83.1M | 3.84% |
| FY2023 | $80.1M | 0.93% |
| FY2022 | $79.3M | 0.45% |
| FY2021 | $79.0M | 0.78% |
| FY2020 | $78.4M | 0.20% |
| FY2019 | $78.2M | 0.34% |
| FY2018 | $77.9M | 0.44% |
| FY2017 | $77.6M | 0.72% |
| FY2016 | $77.0M | 2.87% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $87.6M | 0.68% |
| Mar 2026 | $87.0M | 0.27% |
| Dec 2025 | $86.8M | (0.16%) |
| Sep 2025 | $86.9M | 0.12% |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| PRM Perimeter Solutions, SA compare | $175.0M |
| AVNT Avient Corporation compare | $92.4M |
| CLMT Calumet, Inc. | $87.6M |
| FUL H. B. Fuller Company compare | $54.9M |
| CBT Cabot Corporation compare | $51.9M |
| ASH Ashland Inc. compare | $46.0M |
| SXT Sensient Technologies Corporation compare | $42.8M |
| HWKN Hawkins, Inc. compare | $20.8M |
| WDFC WD-40 Company compare | $13.5M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on CLMT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement